← SynDRA
COPANLISIB
SynDRA canonical compound SYN0037983 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | PIK3CD |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
| Indication | follicular lymphoma |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
- PIK3CA
- PIK3CD
- PIK3CG
- PIK3CB
- MTOR
- RAB27A
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3CA INHIBITOR
- PI3-kinase p110-alpha subunit inhibitor
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PIK3CG MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PDGFRB
- PDE3A
- PASK
- PAK6
- PAK4
- PAK2
- PAICS
- OPRM1
- OPA1
- OLA1
- OGG1
- NUAK2
- NTRK1
- NTHL1
- NQO2
- NLK
- NEK9
- NEK3
- PDE4A
- PDXK
- PRKAR2A
- PEBP1
- PRKAG1
- PRKACG
- PRKACB
- PRKACA
- PRKAA1
- PLK4
- PLK1
- PKN3
- PKN2
- PKN1
- PKMYT1
- PIP4K2C
- PIP4K2A
- PIM1
- PHKG2
- PGR
- PFKP
Drug classes
- Kinase Inhibitors
- Kinase Inhibitor
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- Aliqopa
- BAY 80-6946
- BAY 84-1236
- copanlisib hydrochloride
- copanlisib HCl
- copanlisib hydrochloride hydrate
- BAY-80-6946
- BAY80-6946
- UNII-WI6V529FZ9
- WI6V529FZ9
- AK172384
- BAY 80-6946 (Copanlisib)
- Copanlisib [USAN:INN]
- Copanlisib (USAN/INN)
- GTPL7875
- SCHEMBL1655478
- SCHEMBL13084037
- Copanlisib (BAY 80-6946)
- DTXS
- كوبانليسيب
- Linolosal
- RefChem:1074979
- NCI60_042010
- Dexamethasone 21-(sodium hydrogenphosphate)
- NS00015667
- Betnesol
- Celestone Phosphate
- NS00082062
- Linosal
- FB181436
- SCHEMBL30037357
- DTXCID80197200
Look up COPANLISIB in the interactive SynDRA portal →